NDC11 10135080351
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 10135-0803-51 | 10135-0803 |
| 10135-803-51 | 10135-803 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Regadenoson | REGADENOSON | Marlex Pharmaceuticals, Inc. | 843bfba9-47de-4d76-843a-997bb4564f6e | 2025-02-02 | Warnings, Adverse reactions | 10135-803-51 10135-803 10135080351 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.